Additionally, PD-L1 is negatively regulated by wildtype p53 [37], so fenofibrate reprogramming of the tumor-immune microenvironment may be a direct consequence of reactivation of the p53 tumor suppressor program. This evidence concerns the gene TP53 and neoplasm.